Spots Global Cancer Trial Database for metastatic colon cancer
Every month we try and update this database with for metastatic colon cancer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| A Phase Ⅱ Study of XELOX Chemotherapy With or Without Surgery of Primary Lesion for Colon Cancer Patients | NCT02291744 | Metastatic Colo... | resection of pr... XELOX | 18 Years - 75 Years | Fudan University | |
| Combined Use of Raltitrexed and S-1 as Treatment for Patients With Metastasizing Colorectal Cancer | NCT02618356 | Metastatic Colo... | Raltitrexed and... | 18 Years - 80 Years | Fudan University | |
| A Phase 1-2 of ST316 With Selected Advanced Unresectable and Metastatic Solid Tumors | NCT05848739 | Breast Cancer M... Pancreatic Canc... NSCLC, Metastat... Synovial Sarcom... Colon Cancer Metastatic Colo... Melanoma Recurr... Metastatic Skin... Melanoma Stage ... Triple Negative... TNBC - Triple-N... Cholangiocarcin... Ovarian Cancer Metastatic Mela... Hepatocellular ... | ST316 | 18 Years - | Sapience Therapeutics | |
| Thermal Ablation in Larger Liver and Kidney Tumours | NCT01720706 | Liver and Kidne... | RFA Loosely wou... | 18 Years - | University Health Network, Toronto | |
| Panitumumab and Chemotherapy in Patients With Advanced Colorectal Cancer After Prior Therapy With Bevacizumab | NCT01814501 | Mucinous Adenoc... Mucinous Adenoc... Recurrent Colon... Recurrent Recta... Signet Ring Ade... Signet Ring Ade... Stage IV Colon ... Stage IV Rectal... | panitumumab irinotecan hydr... fluorouracil leucovorin calc... | 18 Years - | Ohio State University Comprehensive Cancer Center | |
| Crossover Evaluation of Effect of Atorvastatin on PK of Irinotecan in CRC Patients Receiving FOLFIRI | NCT01605344 | Advanced Adenoc... | FOLFIRI. Atorvastatin | 18 Years - | UNC Lineberger Comprehensive Cancer Center | |
| A Study to Investigate Ompenaclid Combined With FOLFIRI Plus Bevacizumab in Advanced/Metastatic Colorectal Cancer | NCT05983367 | Colorectal Canc... Metastatic Colo... | Ompenaclid (RGX... Placebo Bevacizumab FOLFIRI regimen | 18 Years - | Inspirna, Inc. | |
| Curcumin in Combination With 5FU for Colon Cancer | NCT02724202 | Metastatic Colo... | Curcumin 5-flurorouracil | 18 Years - | Baylor Research Institute | |
| KRAS-Targeted Vaccine Combined With Balstilimab and Botensilimab for Patients With Stage IV MMR-p Colorectal Cancer and Pancreatic Ductal Cancer | NCT06411691 | Colorectal Canc... Pancreatic Canc... | KRAS Vaccine wi... Balstilimab Botensilimab | 18 Years - | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| The Value of Palliative Primary Tumor Resection in Metastatic Colon Cancer | NCT04416854 | Metastatic Colo... Surgery | resection of pr... XELOX mFOLFOX6 | 18 Years - 75 Years | Fudan University | |
| A Study of Encorafenib Plus Cetuximab Taken Together With Pembrolizumab Compared to Pembrolizumab Alone in People With Previously Untreated Metastatic Colorectal Cancer | NCT05217446 | Metastatic Colo... | Encorafenib Cetuximab Pembrolizumab | 16 Years - | Pfizer | |
| Crossover Evaluation of Effect of Atorvastatin on PK of Irinotecan in CRC Patients Receiving FOLFIRI | NCT01605344 | Advanced Adenoc... | FOLFIRI. Atorvastatin | 18 Years - | UNC Lineberger Comprehensive Cancer Center | |
| Exercise for Gut Microbiome in Patients With Young-Onset Colorectal Cancer Undergoing Chemotherapy: The COURAGE Trial | NCT06202183 | Colorectal Canc... Metastatic Colo... Metastatic Colo... | Exercise Progra... | 18 Years - 50 Years | Dana-Farber Cancer Institute | |
| Study of Immunochemotherapy +/- Hypofractionated Radiation for Complete Response in Solid Tumors | NCT01936961 | Metastatic Non-... Metastatic Colo... Metastatic Trip... | CTLA-4 Antibody Hypofractionate... | 18 Years - | Western Regional Medical Center | |
| Hepatic Artery Infusion (HAI) Program at Duke University | NCT04511793 | Metastatic Colo... Liver Cancer Intrahepatic Ch... | Medtronic Synch... | 18 Years - 80 Years | Duke University | |
| Imaging With [89Zr]Panitumumab-PET/MRI in Patients With Newly Diagnosed Colorectal Cancer | NCT03764137 | Metastatic Colo... | [89Zr]Panitumum... | 19 Years - | University of Alabama at Birmingham | |
| A Study of Efficacy and Safety of Fruquintinib (HMPL-013) in Participants With Metastatic Colorectal Cancer | NCT04322539 | Metastatic Colo... Metastatic Colo... | Fruquintinib Placebo | 18 Years - | Hutchmed | |
| A Study to Investigate Ompenaclid Combined With FOLFIRI Plus Bevacizumab in Advanced/Metastatic Colorectal Cancer | NCT05983367 | Colorectal Canc... Metastatic Colo... | Ompenaclid (RGX... Placebo Bevacizumab FOLFIRI regimen | 18 Years - | Inspirna, Inc. | |
| Neoantigen-Targeted Vaccine Combined With Anti-PD-1 Antibody for Patients With Stage IV MMR-p Colon and Pancreatic Ductal Cancer | NCT04799431 | Pancreatic Canc... Colorectal Canc... | Neoantigen Vacc... Retifanlimab | 18 Years - | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| A Multi-Center, Open-Label Study of Fruquintinib in Solid Tumors, Colorectal, and Breast Cancer | NCT03251378 | Advanced Solid ... Metastatic Colo... Metastatic Brea... Triple Negative... HER2-negative B... Hormone Recepto... Rectal Cancer | Fruquintinib (H... | 18 Years - | Hutchmed | |
| A Study to Assess PV-10 Chemoablation of Cancer of the Liver | NCT00986661 | Cancer Metastat... Hepatocellular ... Metastatic Mela... Metastatic Ocul... Metastatic Uvea... Metastatic Lung... Metastatic Colo... Metastatic Colo... Metastatic Brea... Metastatic Panc... | PV-10 (10% rose... | 18 Years - | Provectus Pharmaceuticals | |
| Cellular Immune Augmentation in Colon and Rectal Cancer | NCT00257322 | Colon Cancer Rectal Cancer | GM-CSF | 18 Years - | University of California, Irvine | |
| Topical Tretinoin Prophylaxis for Anti-EGFR Induced Skin Toxicity in Metastatic Colorectal Cancer | NCT06358677 | Metastatic Colo... Metastatic Rect... | Topical Tretino... Placebo | 18 Years - | University of Utah | |
| A Phase 1-2 of ST316 With Selected Advanced Unresectable and Metastatic Solid Tumors | NCT05848739 | Breast Cancer M... Pancreatic Canc... NSCLC, Metastat... Synovial Sarcom... Colon Cancer Metastatic Colo... Melanoma Recurr... Metastatic Skin... Melanoma Stage ... Triple Negative... TNBC - Triple-N... Cholangiocarcin... Ovarian Cancer Metastatic Mela... Hepatocellular ... | ST316 | 18 Years - | Sapience Therapeutics | |
| Evaluation of Pathway Modulation by Raf, MEK, & Kinase Inhibitors | NCT03176485 | Metastatic Canc... Melanoma Colon Cancer Differentiated ... Hepatocellular ... Renal Cell Carc... Metastatic Mela... HCC Metastatic Colo... | Solar Simulator | 18 Years - | University of Arizona | |
| Dose Escalating Study of Foxy-5 in Breast-, Colon- or Prostate Cancer Patients | NCT02655952 | Metastatic Brea... Metastatic Colo... Metastatic Pros... | Foxy-5 | 18 Years - | WntResearch AB | |
| Cellular Immune Augmentation in Colon and Rectal Cancer | NCT00257322 | Colon Cancer Rectal Cancer | GM-CSF | 18 Years - | University of California, Irvine | |
| Identification and Treatment Of Micrometastatic Disease in Stage III Colon Cancer | NCT03803553 | Metastatic Colo... Stage III Colon... | FOLFIRI Protoco... ACTIVE SURVEILL... Nivolumab Proto... Encorafenib/Bin... Trastuzumab + P... | 18 Years - | Massachusetts General Hospital | |
| Cellular Immune Augmentation in Colon and Rectal Cancer | NCT00257322 | Colon Cancer Rectal Cancer | GM-CSF | 18 Years - | University of California, Irvine | |
| A Phase Ⅱ Study of XELOX Chemotherapy With or Without Surgery of Primary Lesion for Colon Cancer Patients | NCT02291744 | Metastatic Colo... | resection of pr... XELOX | 18 Years - 75 Years | Fudan University | |
| Palbociclib and Cetuximab in Metastatic Colorectal Cancer | NCT03446157 | Cancer of the C... Colon Cancer Colon Neoplasms Colonic Cancer Neoplasms, Colo... | Cetuximab Palbociclib | 18 Years - 99 Years | UNC Lineberger Comprehensive Cancer Center | |
| Detection of Brain Metastasis by MRI in Metastatic Colorectal Cancer Patients | NCT03694938 | Metastatic Colo... | Magnetic resona... | 18 Years - | Poitiers University Hospital | |
| Exercise for Gut Microbiome in Patients With Young-Onset Colorectal Cancer Undergoing Chemotherapy: The COURAGE Trial | NCT06202183 | Colorectal Canc... Metastatic Colo... Metastatic Colo... | Exercise Progra... | 18 Years - 50 Years | Dana-Farber Cancer Institute | |
| Detection of Brain Metastasis by MRI in Metastatic Colorectal Cancer Patients | NCT03694938 | Metastatic Colo... | Magnetic resona... | 18 Years - | Poitiers University Hospital | |
| ZETA : Prospective Observational Study | NCT03730558 | Metastatic Colo... | aflibercept + F... | 18 Years - | Institut Sainte Catherine | |
| Thermal Ablation in Larger Liver and Kidney Tumours | NCT01720706 | Liver and Kidne... | RFA Loosely wou... | 18 Years - | University Health Network, Toronto | |
| REVERT - taRgeted thErapy for adVanced colorEctal canceR paTients | NCT05396807 | Metastatic Colo... | AI | 18 Years - | University of Rome Tor Vergata | |
| SGM-101 in Colorectal Lung Metastases | NCT04737213 | Colorectal Canc... Metastatic Colo... | SGM-101 | 18 Years - | Leiden University Medical Center | |
| Palbociclib and Cetuximab in Metastatic Colorectal Cancer | NCT03446157 | Cancer of the C... Colon Cancer Colon Neoplasms Colonic Cancer Neoplasms, Colo... | Cetuximab Palbociclib | 18 Years - 99 Years | UNC Lineberger Comprehensive Cancer Center | |
| Evaluation of Hypertension as a Predictor of Efficacy Bevacizumab in Metastatic Breast Cancer and Colorectal Cancer | NCT01733628 | Metastatic Colo... Metastatic Brea... | 18 Years - | Spanish Breast Cancer Research Group | ||
| Hepatic Artery Infusion (HAI) Program at Duke University | NCT04511793 | Metastatic Colo... Liver Cancer Intrahepatic Ch... | Medtronic Synch... | 18 Years - 80 Years | Duke University | |
| Observational Study to Evaluate the Use of Targeted Therapies in Metastatic Colorectal Cancer | NCT02254941 | Metastatic Colo... | Chemotherapy Chemotherapy pl... | 18 Years - | Grupo Espanol Multidisciplinario del Cancer Digestivo | |
| Evaluation of Hypertension as a Predictor of Efficacy Bevacizumab in Metastatic Breast Cancer and Colorectal Cancer | NCT01733628 | Metastatic Colo... Metastatic Brea... | 18 Years - | Spanish Breast Cancer Research Group | ||
| A Study to Investigate Ompenaclid Combined With FOLFIRI Plus Bevacizumab in Advanced/Metastatic Colorectal Cancer | NCT05983367 | Colorectal Canc... Metastatic Colo... | Ompenaclid (RGX... Placebo Bevacizumab FOLFIRI regimen | 18 Years - | Inspirna, Inc. | |
| Evaluation of Pathway Modulation by Raf, MEK, & Kinase Inhibitors | NCT03176485 | Metastatic Canc... Melanoma Colon Cancer Differentiated ... Hepatocellular ... Renal Cell Carc... Metastatic Mela... HCC Metastatic Colo... | Solar Simulator | 18 Years - | University of Arizona | |
| CALM: Managing Distress in Malignant Brain Cancer | NCT06180460 | Brain Tumor Brain Metastase... Brain Cancer Metastatic Lung... Metastatic Brea... Metastatic Mela... Metastatic Colo... Metastatic Kidn... | CALM Treatment as us... | 18 Years - | Virginia Commonwealth University | |
| Study of Skin Toxicity of Cetuximab: Find a Link Between Skin Inflammation and Tumor Response | NCT01292356 | Metastatic Colo... | cetuximab | 18 Years - | Poitiers University Hospital | |
| Pembrolizumab + Poly-ICLC in MRP Colon Cancer | NCT02834052 | Metastatic Colo... Solid Tumor | pembrolizumab Poly-ICLC | 18 Years - | Augusta University | |
| PD1 Antibody Combined With mFOLFOX6 Neoadjuvant Therapy for Advanced Resectable Metastatic Colon Cancer | NCT06335147 | Metastatic Colo... | Serplulimab, mF... | 18 Years - 75 Years | Henan Cancer Hospital | |
| Detection of Brain Metastasis by MRI in Metastatic Colorectal Cancer Patients | NCT03694938 | Metastatic Colo... | Magnetic resona... | 18 Years - | Poitiers University Hospital | |
| Evaluation of the NantHealth GPS Cancer Test in Patients With Advanced Cancers | NCT03073473 | Pancreatic Canc... Metastatic Brea... Metastatic Lung... Metastatic Colo... Metastatic Mela... Metastatic Pros... | NantHealth GPS ... | 18 Years - | Cota Inc. | |
| A Study to Assess PV-10 Chemoablation of Cancer of the Liver | NCT00986661 | Cancer Metastat... Hepatocellular ... Metastatic Mela... Metastatic Ocul... Metastatic Uvea... Metastatic Lung... Metastatic Colo... Metastatic Colo... Metastatic Brea... Metastatic Panc... | PV-10 (10% rose... | 18 Years - | Provectus Pharmaceuticals | |
| Safety, Efficacy, and Dosing of Stereotactic Radiosurgery for Hepato-cellular Carc/Colo-rectal Liver Metastases | NCT01528878 | Liver Neoplasms Colonic Neoplas... Metastatic Canc... | Stereotactic Ra... | 18 Years - | UNC Lineberger Comprehensive Cancer Center | |
| A Study of Encorafenib Plus Cetuximab Taken Together With Pembrolizumab Compared to Pembrolizumab Alone in People With Previously Untreated Metastatic Colorectal Cancer | NCT05217446 | Metastatic Colo... | Encorafenib Cetuximab Pembrolizumab | 16 Years - | Pfizer | |
| A Study of Efficacy and Safety of Fruquintinib (HMPL-013) in Participants With Metastatic Colorectal Cancer | NCT04322539 | Metastatic Colo... Metastatic Colo... | Fruquintinib Placebo | 18 Years - | Hutchmed | |
| The Value of Palliative Primary Tumor Resection in Metastatic Colon Cancer | NCT04416854 | Metastatic Colo... Surgery | resection of pr... XELOX mFOLFOX6 | 18 Years - 75 Years | Fudan University | |
| ZETA : Prospective Observational Study | NCT03730558 | Metastatic Colo... | aflibercept + F... | 18 Years - | Institut Sainte Catherine | |
| SGM-101 in Colorectal Lung Metastases | NCT04737213 | Colorectal Canc... Metastatic Colo... | SGM-101 | 18 Years - | Leiden University Medical Center | |
| A Study of Encorafenib Plus Cetuximab Taken Together With Pembrolizumab Compared to Pembrolizumab Alone in People With Previously Untreated Metastatic Colorectal Cancer | NCT05217446 | Metastatic Colo... | Encorafenib Cetuximab Pembrolizumab | 16 Years - | Pfizer |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
